USANA Health Sciences (USNA) Misses Q4 EPS by 7c, FY Guidance Misses Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
USANA Health Sciences Reports Fourth Quarter and Full-Year Financial Results
February 7, 2017 4:15 PM ESTFourth quarter net sales increased 8.7% to $252.9 million, up 12.7% in constant currency Number of active Associates at quarter-end increased 11.9% to 471,000 Fourth quarter EPS decreased 5.4% to $0.871 For the year, net sales increased 9.5% to a record $1.006 billion, up 14.1% in constant currency For the year, EPS increased 11.1% to a record $3.991 Company provides 2017 Outlook
SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results... More
